Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Until today this year the stock’s price performance recorded a decrease of -32.58%. However, over the last six months, the performance has been weaker by 25.35%. The price of CUE increased 162.00% over the last 30 days. And in the last five days, it has surged by 5.95%.
The market performance of Cue Biopharma Inc has been somewhat unstable. Over the past year, the company’s stock achieved a high of $3.25 on 12/08/23, with the lowest value for the same timeframe being $0.45, recorded on 09/26/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of CUE Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Cue Biopharma Inc’s current trading price is -45.22% away from its 52-week high, while its distance from the 52-week low is 295.56%. The stock’s price range over this timeframe has been between $0.45 and $3.25. The shares of the Healthcare sector company recorded a trading volume of approximately 0.86 million for the day, which was comparatively higher than the average daily volume of 0.69 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Cue Biopharma Inc (CUE) has experienced a quarterly rise of 132.68% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 107.17M and boasts a workforce of 53 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.9409, with a change in price of +0.1300. Similarly, Cue Biopharma Inc recorded 614,420 in trading volume during the last 100 days, posting a change of +7.88%.
CUE’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for CUE stands at 0.52. Similarly, the long-term debt-to-equity ratio is also 0.20.
CUE Stock Stochastic Average
Cue Biopharma Inc’s raw stochastic average for the past 50 days is currently at 91.72%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 90.16%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 77.43% and 76.08%, respectively.
